EyeGate Pharma Announces Positive Results in Second PRK Study

Go back to EyeGate Pharma Announces Positive Results in Second PRK Study
(NASDAQ: EYEG) Delayed: 33.87 +0.01 (0.03%)
Previous Close $33.86    52 Week High $5.09 
Open $33.84    52 Week Low $1.11 
Day High $33.87    P/E N/A 
Day Low $33.84    EPS $0.00 
Volume 905